Eva Fortea Verdejo's Stock Ratings Wells Fargo Analyst Eva Fortea Verdejo is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating ...

We just received data on a new analyst forecast for $BCAX. Eva Fortea Verdejo from Wells Fargo set a price target of 8.0 for BCAX. Multiple analysts have issued price ...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) is one of the most promising mid-cap healthcare stocks under $50. On December 12, Wells Fargo analyst Eva Fortea Verdejo indicated her bullish ...

$RCUS insiders have traded $RCUS stock on the open market 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales. Here’s a ...

Wells Fargo analyst Eva Fortea Verdejo initiated coverage of Xencor (XNCR) with an Overweight rating and $37 price target The firm doesn’t think the Street is pricing in enough value for Xencor’s ...

Wells Fargo analyst Eva Fortea Verdejo maintained a Buy rating on Revolution Medicines today and set a price target of $70.00. According to TipRanks, Fortea Verdejo is a 5-star analyst with an average ...

Eva Fortea Verdejo is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future ...

Wells Fargo analyst Eva Fortea Verdejo maintained a Buy rating on Revolution Medicines yesterday and set a price target of $144.00. The company’s shares closed yesterday at $98.64. Fortea Verdejo ...